Found this post on the Nasdaq which some might find interesting
http://seekingalpha.com/article/1631602-an-incredibly-asymmetric-risk-reward-ratio-for-sanuwave-foreshadows-huge-upside?source=nasdaq
Nice rise on the NASDAQ today to $9.14
On December 11, 2012, I discussed Sunshine Heart (SSH), where I highlighted the following from the company's preliminary data from the pilot study: "Two patients were permanently disconnected from the device after reporting no further heart failure symptoms and were discharged from a heart failure program." I stated it could have huge implications for the CHF market as a whole, essentially castrating Thoratec and Heartware's offerings, and something to look out for in future releases. When I revisited Sunshine Heart on 5/15/13 after the release of Q1 results, I noticed the confirmation of my previous observation and noted that it appeared to be the beginning of what looks to be a very exciting year for its shareholders... SSH has since appreciated over 60%.
Add to My Watchlist
What is My Watchlist?